intensive care national audit and research centre
intensive care national audit and research centre Company Information
Group Structure
View All
Industry
Research and experimental development on social sciences and humanities
Registered Address
napier house, 24 high holborn, london, WC1V 6AZ
Website
http://icnarc.orgintensive care national audit and research centre Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE at £6.9m based on a Turnover of £5.9m and 1.16x industry multiple (adjusted for size and gross margin).
intensive care national audit and research centre Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE at £1.8m based on an EBITDA of £266.8k and a 6.57x industry multiple (adjusted for size and gross margin).
intensive care national audit and research centre Estimated Valuation
Pomanda estimates the enterprise value of INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE at £11.7m based on Net Assets of £3.3m and 3.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Intensive Care National Audit And Research Centre Overview
Intensive Care National Audit And Research Centre is a live company located in london, WC1V 6AZ with a Companies House number of 02946727. It operates in the research and experimental development on social sciences and humanities sector, SIC Code 72200. Founded in July 1994, it's largest shareholder is unknown. Intensive Care National Audit And Research Centre is a mature, mid sized company, Pomanda has estimated its turnover at £5.9m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Intensive Care National Audit And Research Centre Health Check
Pomanda's financial health check has awarded Intensive Care National Audit And Research Centre a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 2 areas for improvement. Company Health Check FAQs
4 Strong
5 Regular
2 Weak
Size
annual sales of £5.9m, make it larger than the average company (£756.2k)
£5.9m - Intensive Care National Audit And Research Centre
£756.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a faster rate (7.5%)
16% - Intensive Care National Audit And Research Centre
7.5% - Industry AVG
Production
with a gross margin of 64.1%, this company has a comparable cost of product (64.1%)
64.1% - Intensive Care National Audit And Research Centre
64.1% - Industry AVG
Profitability
an operating margin of 4.1% make it as profitable than the average company (4.1%)
4.1% - Intensive Care National Audit And Research Centre
4.1% - Industry AVG
Employees
with 56 employees, this is above the industry average (14)
56 - Intensive Care National Audit And Research Centre
14 - Industry AVG
Pay Structure
on an average salary of £52.7k, the company has an equivalent pay structure (£50.2k)
£52.7k - Intensive Care National Audit And Research Centre
£50.2k - Industry AVG
Efficiency
resulting in sales per employee of £106k, this is equally as efficient (£95.3k)
£106k - Intensive Care National Audit And Research Centre
£95.3k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is later than average (29 days)
50 days - Intensive Care National Audit And Research Centre
29 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (23 days)
44 days - Intensive Care National Audit And Research Centre
23 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Intensive Care National Audit And Research Centre
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 72 weeks, this is average cash available to meet short term requirements (77 weeks)
72 weeks - Intensive Care National Audit And Research Centre
77 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 55.9%, this is a higher level of debt than the average (35.7%)
55.9% - Intensive Care National Audit And Research Centre
35.7% - Industry AVG
INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE financials
Intensive Care National Audit And Research Centre's latest turnover from December 2023 is £5.9 million and the company has net assets of £3.3 million. According to their latest financial statements, Intensive Care National Audit And Research Centre has 56 employees and maintains cash reserves of £5.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5,937,003 | 5,084,396 | 4,954,122 | 3,852,361 | 2,741,729 | 2,890,784 | 2,969,229 | 2,631,437 | 2,160,804 | 2,879,637 | 2,447,458 | 3,007,786 | 2,568,406 | 1,758,810 | 1,549,811 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | 400,246 | 711,067 | 1,331,935 | 234,307 | -5,524 | 200,974 | 139,442 | 88,183 | -44,235 | 2,957 | -35,439 | -69,172 | -133,142 | -202,281 | 161,279 |
| Tax | |||||||||||||||
| Profit After Tax | 400,246 | 711,067 | 1,331,935 | 234,307 | -5,524 | 200,974 | 139,442 | 88,183 | -44,235 | 2,957 | -35,439 | -69,172 | -133,142 | -202,281 | 161,279 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 400,246 | 711,067 | 1,331,935 | 234,307 | -5,524 | 200,974 | 139,442 | 88,183 | -44,235 | 2,957 | -35,439 | -69,172 | -133,142 | -202,281 | 161,279 |
| Employee Costs | 2,952,335 | 2,568,660 | 2,192,973 | 1,844,542 | 1,660,514 | 1,420,567 | 1,514,135 | 1,514,398 | 1,493,761 | 1,621,897 | 1,361,523 | 1,341,772 | 1,466,607 | 1,188,300 | 859,823 |
| Number Of Employees | 56 | 50 | 45 | 40 | 38 | 34 | 37 | 37 | 37 | 40 | 36 | 34 | 37 | 30 | 22 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 30,713 | 23,922 | 22,803 | 26,141 | 86,608 | 86,605 | 58,230 | 65,881 | 53,122 | 72,203 | 95,166 | 75,149 | 35,390 | 48,664 | 32,275 |
| Intangible Assets | 241,597 | 119,203 | |||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 30,713 | 23,922 | 22,803 | 26,141 | 328,205 | 205,808 | 58,230 | 65,881 | 53,122 | 72,203 | 95,166 | 75,149 | 35,390 | 48,664 | 32,275 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 815,899 | 803,046 | 779,932 | 1,372,280 | 345,759 | 532,934 | 425,222 | 361,703 | 332,609 | 186,959 | 131,079 | 182,726 | 280,711 | ||
| Group Debtors | |||||||||||||||
| Misc Debtors | 1,062,325 | 1,040,770 | 2,114,329 | 1,338,652 | 862,513 | 734,468 | 244,328 | 436,498 | 385,135 | 436,710 | 366,698 | 444,157 | 219,989 | 417,171 | 508,429 |
| Cash | 5,684,849 | 5,427,513 | 3,199,119 | 1,205,133 | 1,442,457 | 1,520,517 | 2,085,912 | 1,360,698 | 1,563,658 | 1,457,565 | 1,207,060 | 1,029,148 | 1,284,487 | 1,248,002 | 885,101 |
| misc current assets | |||||||||||||||
| total current assets | 7,563,073 | 7,271,329 | 6,093,380 | 3,916,065 | 2,650,729 | 2,787,919 | 2,755,462 | 2,158,899 | 2,281,402 | 2,081,234 | 1,704,837 | 1,656,031 | 1,785,187 | 1,665,173 | 1,393,530 |
| total assets | 7,593,786 | 7,295,251 | 6,116,183 | 3,942,206 | 2,978,934 | 2,993,727 | 2,813,692 | 2,224,780 | 2,334,524 | 2,153,437 | 1,800,003 | 1,731,180 | 1,820,577 | 1,713,837 | 1,425,805 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 258,352 | 211,289 | 112,850 | 145,340 | 66,034 | 176,152 | 78,285 | 83,474 | 166,759 | 73,399 | 96,971 | 98,540 | 117,758 | 8,153 | 40,520 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 3,837,345 | 3,986,119 | 3,566,557 | 2,767,024 | 2,242,366 | 2,141,517 | 2,260,323 | 1,805,664 | 1,920,305 | 1,788,343 | 1,414,294 | 1,308,463 | 1,309,470 | 1,179,193 | 656,513 |
| total current liabilities | 4,095,697 | 4,197,408 | 3,679,407 | 2,912,364 | 2,308,400 | 2,317,669 | 2,338,608 | 1,889,138 | 2,087,064 | 1,861,742 | 1,511,265 | 1,407,003 | 1,427,228 | 1,187,346 | 697,033 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 150,000 | 150,000 | 150,000 | 75,000 | |||||||||||
| provisions | 50,000 | 50,000 | |||||||||||||
| total long term liabilities | 150,000 | 150,000 | 200,000 | 125,000 | |||||||||||
| total liabilities | 4,245,697 | 4,347,408 | 3,879,407 | 3,037,364 | 2,308,400 | 2,317,669 | 2,338,608 | 1,889,138 | 2,087,064 | 1,861,742 | 1,511,265 | 1,407,003 | 1,427,228 | 1,187,346 | 697,033 |
| net assets | 3,348,089 | 2,947,843 | 2,236,776 | 904,842 | 670,534 | 676,058 | 475,084 | 335,642 | 247,460 | 291,695 | 288,738 | 324,177 | 393,349 | 526,491 | 728,772 |
| total shareholders funds | 3,348,089 | 2,947,843 | 2,236,776 | 904,842 | 670,534 | 676,058 | 475,084 | 335,642 | 247,460 | 291,695 | 288,738 | 324,177 | 393,349 | 526,491 | 728,772 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 24,886 | 17,717 | 16,575 | 60,319 | 27,038 | 22,512 | 36,637 | 34,675 | 34,541 | 28,879 | 26,469 | 19,382 | 18,513 | 11,706 | |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 34,408 | -1,050,445 | 183,329 | 1,502,660 | -59,130 | 597,852 | -128,651 | 80,457 | 94,075 | 125,892 | -129,106 | 126,183 | 83,529 | -91,258 | 508,429 |
| Creditors | 47,063 | 98,439 | -32,490 | 79,306 | -110,118 | 97,867 | -5,189 | -83,285 | 93,360 | -23,572 | -1,569 | -19,218 | 109,605 | -32,367 | 40,520 |
| Accruals and Deferred Income | -148,774 | 419,562 | 799,533 | 524,658 | 100,849 | -118,806 | 454,659 | -114,641 | 131,962 | 374,049 | 105,831 | -1,007 | 130,277 | 522,680 | 656,513 |
| Deferred Taxes & Provisions | -50,000 | 50,000 | |||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | -174,616 | -14,860 | -49,397 | -15,593 | -11,579 | ||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | -174,616 | -14,860 | -49,397 | -15,593 | -11,579 | ||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | 75,000 | 75,000 | |||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 74,999 | 75,001 | -1 | 567,493 | |||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 257,336 | 2,228,394 | 1,993,986 | -237,324 | -78,060 | -565,395 | 725,214 | -202,960 | 106,093 | 250,505 | 177,912 | -255,339 | 36,485 | 362,901 | 885,101 |
| overdraft | |||||||||||||||
| change in cash | 257,336 | 2,228,394 | 1,993,986 | -237,324 | -78,060 | -565,395 | 725,214 | -202,960 | 106,093 | 250,505 | 177,912 | -255,339 | 36,485 | 362,901 | 885,101 |
intensive care national audit and research centre Credit Report and Business Information
Intensive Care National Audit And Research Centre Competitor Analysis
Perform a competitor analysis for intensive care national audit and research centre by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in WC1V area or any other competitors across 12 key performance metrics.
intensive care national audit and research centre Ownership
INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE group structure
Intensive Care National Audit And Research Centre has no subsidiary companies.
Ultimate parent company
INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE
02946727
intensive care national audit and research centre directors
Intensive Care National Audit And Research Centre currently has 12 directors. The longest serving directors include Professor David Menon (Apr 2004) and Ms Lisa Hinton (Feb 2009).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor David Menon | 68 years | Apr 2004 | - | Director | |
| Ms Lisa Hinton | United Kingdom | 55 years | Feb 2009 | - | Director |
| Dr Gareth Sellors | 54 years | Dec 2015 | - | Director | |
| Dr Timothy Gould | 64 years | Dec 2015 | - | Director | |
| Mrs Susan James | 69 years | Jan 2019 | - | Director | |
| Professor Ruth Endacott | United Kingdom | 65 years | Jan 2019 | - | Director |
| Dr Tamas Szakmany | 48 years | Apr 2022 | - | Director | |
| Dr Manu Shankar-Hari | 50 years | Apr 2022 | - | Director | |
| Mr Richard Grieve | 51 years | Apr 2022 | - | Director | |
| Ms Vikki Williams | 54 years | May 2023 | - | Director |
P&L
December 2023turnover
5.9m
+17%
operating profit
242k
0%
gross margin
64.1%
-13.15%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
3.3m
+0.14%
total assets
7.6m
+0.04%
cash
5.7m
+0.05%
net assets
Total assets minus all liabilities
intensive care national audit and research centre company details
company number
02946727
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
72200 - Research and experimental development on social sciences and humanities
incorporation date
July 1994
age
31
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
MHA
address
napier house, 24 high holborn, london, WC1V 6AZ
Bank
UNITY TRUST BANK
Legal Advisor
-
intensive care national audit and research centre Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to intensive care national audit and research centre.
intensive care national audit and research centre Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INTENSIVE CARE NATIONAL AUDIT AND RESEARCH CENTRE. This can take several minutes, an email will notify you when this has completed.
intensive care national audit and research centre Companies House Filings - See Documents
| date | description | view/download |
|---|
